[Study on solid dispersion of copovidone-based tanshinone II(A)]

Area of Science:

• Pharmaceutical Sciences
• Materials Science

Background:

• Tanshinone II(A) (TS II(A)) exhibits poor in vitro dissolution and high moisture absorption.
• Developing effective drug delivery systems is crucial for enhancing TS II(A) bioavailability.

Purpose of the Study:

• To prepare tanshinone II(A) solid dispersion using copovidone (PVP-S630).
• To improve the in vitro dissolution rate of TS II(A).
• To reduce the moisture absorption of the TS II(A) solid dispersion.

Main Methods:

• Spray drying was employed to formulate the TS II(A) solid dispersion.
• Characterization involved Scanning Electron Microscopy (SEM), Differential Scanning Calorimetry (DSC), and X-ray Diffraction (XRD).
• Dissolution, moisture absorption, and stability were evaluated.

Main Results:

• A 1:10 ratio of TS II(A) to copovidone resulted in amorphous TS II(A) dispersed on the carrier surface.
• Achieved 100% in vitro dissolution within 0.5 hours.
• Demonstrated lower moisture absorption compared to PVP-K30 solid dispersion.
• Exhibited no significant changes in drug dissolution or content after a three-month accelerated stability test.

Conclusions:

• Copovidone is an effective carrier for TS II(A) solid dispersion.
• The prepared solid dispersion significantly enhances TS II(A) dissolution.
• The formulation shows favorable low moisture absorption and high stability.
• This solid dispersion holds considerable potential for pharmaceutical applications.